SCHEMBL2178099

SCHEMBL2178099

CC(C)(C)OC(=O)NCCC(O)c1cccc(N(Cc2ccccc2)C(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.42
AKT1 P31749 3/20 0.42
BACE1 P56817 3/20 0.42
CTSS P25774 4/20 0.41
CTSL P07711 2/20 0.41
CTSB P07858 2/20 0.41
NPC1 O15118 1/20 0.40
JAK2 O60674 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
PAX8 Q06710 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
PTGES O14684 1/20 0.39
SYK P43405 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CTSK P43235 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2177713 0.94 BACE1 (0.44) IDO1AKT1BACE1CTSSCTSL
SCHEMBL2158118 0.90 SIGMAR1 (0.43) IDO1BACE1CTSSCTSLCTSB
SCHEMBL2821039 0.85 GPR88 (0.39) IDO1BACE1CTSSITGB1ITGA4
SCHEMBL2818137 0.85 L3MBTL1 (0.46) IDO1BACE1CTSSHTTSYK
SCHEMBL2797442 0.84 EPHX1 (0.36) CTSSNR1H4MEN1KMT2ACTSK
SCHEMBL614479 0.83 CTSK (0.47) IDO1CTSSCTSLCTSBSYK
SCHEMBL1521024 0.81 RIPK1 (0.53) IDO1CTSSSYKMEN1KMT2A
SCHEMBL16084764 0.81 RIPK1 (0.53) IDO1CTSSSYKMEN1KMT2A
SCHEMBL2176308 0.81 L3MBTL1 (0.50) IDO1BACE1CTSSHTTSYK
SCHEMBL2179437 0.79 ITGB1 (0.40) BACE1ITGB1ITGA4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2340242-A2 COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2011-07-06 EP disclosed
WO-2010048332-A2 COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-04-29 WO disclosed